OA17543A - Pharmaceutical composition for treating headache, and preparation method thereof. - Google Patents

Pharmaceutical composition for treating headache, and preparation method thereof. Download PDF

Info

Publication number
OA17543A
OA17543A OA1201500253 OA17543A OA 17543 A OA17543 A OA 17543A OA 1201500253 OA1201500253 OA 1201500253 OA 17543 A OA17543 A OA 17543A
Authority
OA
OAPI
Prior art keywords
éthanol
extract
filtered
préparation
give
Prior art date
Application number
OA1201500253
Inventor
Xijun Yan
Naifeng Wu
Shunnan Zhang
Jianhui Yang
Yan Liu
Xingyun SHAO
Song Gao
Lina Dong
Xiaolin Bai
Yan Sun
Bo Xu
Yongfeng Zheng
Lijun Fan
Original Assignee
Tasly Pharmaceutical Group Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tasly Pharmaceutical Group Co., Ltd. filed Critical Tasly Pharmaceutical Group Co., Ltd.
Publication of OA17543A publication Critical patent/OA17543A/en

Links

Abstract

A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.

Description

PHARMACEUTICAL COMPOSITION FOR TREATING HEADACHE, AND PREPARATION METHOD THEREOF
FIELD OF THE INVENTION
The présent invention relates to the field of Traditional Chinese medicine (TCM). More specifically, the invention relates to pharmaceutical composition for treating headache, préparative method and its use thereof.
BACKGROUD OF THE INVENTION io Headache is a common symptom in daily life. Almost everyone will hâve headache in lifetime. The causes of headache are varied. By now, there are a lot of drugs for treating headache abroad or in China, most of which, however, focus on symptomatic treatment of stopping ache (in very few cases, headache is treated by surgery). The results are not satisfactory, because the drugs focus on symptomatic treatment rather than root cause. As a resuit of this, headache attacks patients recurrently. Long-term use of analgésie agents may cause drug résistance and addiction, so the drug of this kind should not be used for long time. Yet, the headache cannot be cured radically. Besides, according to conditions with different causes, there are different sorts of drugs applied clinically, e.g. the anti-anxiety agent, anti-depressant agent, sympathetic inhibitor, calcium channel blockers and antiepileptic agents etc. Due to their severe side effects, long-term administration will make their efficacy reduced so much that the patients hâve to increase dose of drug gradually. The resuit, however, is not satisfactory. The more drugs they take, the severer the headache is. Now, Zhengtian pill (Zhengtianwan) is a Traditional Chinese medicine (TCM) whose formula comprises both TCM and chemical drug. The TCM works by a mechanism of activating blood by removing stasis and the chemical drug stopping pain. In practice, its curative effect is not definite to achieve the purpose of curing radically. Now, there are a lot of TCMs for treating headache. But most of them take effect more slowly; and this drawback will influence life quality of the patients.
Chinese Patent (No. ZL 93100050.5) disclosed a médicinal composition comprising 11 TCMs of Radix Angeiicae Sinensis (Dang gui) and Rhizoma Chuanxiong (Chuan xiong), Radix Paeoniae aiba (Bai shao), Radix Rehmanniae Preparata (Shu dihuang), Ramuius Uncariae cum Uncis (Gou teng), Cauiis Spathoiobi (Ji Xueteng), Spica Pruneiiae (Xia Kucao), Semen Cassiae (Jue mingzi), Concha Margaritifera Usta (Zhen zhumu), Rhizoma Corydaiis (Yuan hu) and Asarum herb (Xi xin). It is the fruits of long-term clinical practice under the guidance of Chinese medicine theory, having the therapeutic effects of treating headache caused by inner damage. Clinically, it can be applied to treat several headache diseases, such as the angioneurotic headache, migraine, and some symptoms like dizziness and headache etc. caused by hypertension. According to the proportion of this recipe, the granule of this composition is produced by Tasly Pharmaceutical Group Co. Ltd., named as Yang
Xue Qing Nao Granule. The functions and indications approved by the authorities are nourishing blood and calming liver, activating blood and removing obstruction in channels, used for diverse types of headache elicited by blood deficiency and hyperactivity of liver, traumatic cranial nerve syndrome, dizziness and vertigo, 5 vexation and irritation, insomnia and dreaminess. In clinic, it has been usually used for treatment headache caused by blood deficiency, blood stasis, and deficiency of Yin and hyperactivity of Yang. Since coming into the market, Yang Xue Qing Nao Granule has gained wide popularity among the patients due to its reassured therapeutic effects.
Now, it has been literarily reported that the Yang Xue Qing Nao Granule is usually prepared by the following method. The 11 TCMs are extracted with water, which is precipitated with éthanol to give the extract, and then the extract is mixed with excipients to préparé into various kinds of pharmaceutical formulations. For example, Chinese patents (No. 03140844.3, 200410019825.4) disclosed a process that the 11
TCMs were mixed in proportion, extracted with water for 3 times, combined to get an extract after appropriate concentration, which was added with 2 fold of éthanol to leave it to stand still for 24 hours to precipitate to get supernatant. The supernatant was concentrated to an extract with relative density of 1.3-1.4. The yield rate was 10%. Aforesaid extract was mixed with sucrose and dextrin in a proportion of 1:3:1 to make granule.
However, due to the different nature of each TCM, the extraction of active ingrédients by using method of extracting ail together usually results in the extraction incomplète or raises the defect of low yield rate. For example, main ingrédients of Radix Angelicae Sinensis (Dang gui) and Rhizoma Chuanxiong (Chuan xiong) are éthanol 25 soluble, so the éthanol was better. In the same manner, the Ramulus Uncariae cum
Uncis contains a variety of indole alkaloids, which is dominated by rhynchophylline and isorhynchophylline and a small amount of flavone constituents. Its water décoction and extract are proved to hâve significantly bio-active effects of sédation, analgesia and antihypertension. Thus, the extraction by water is a more suitable.
As shown in Chinese patents (200510073290.3 and 200510014828.3), 11 TCMs were disclosed, in which Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba and Rhizoma Corydaiis were refluxed with éthanol to hâve a refluxing solution, the residue was mixed with the other 6 TCMs (excluding Ramulus Uncariae cum Uncis} including Radix Rehmanniae Preparata etc. and extracted with water for 3 times.
During the process of 3rd décoction, the Ramulus Uncariae cum Uncis was added, and the extraction liquid was combined to concentrate in vacuum. Ethanol was used to precipitate and the obtained solution was left standing still. After being filtered, the filtrate was mixed with aforesaid refluxing solution, and éthanol was recovered under reduced pressure, concentrated and dried to obtain the extract.
In practice, however, extracting Radix Paeoniae aiba combined with other TCMs will resuit in the final extract somewhat less in melting ability. Later addition of the Ramulus Uncariae cum Uncis into the extract may get the medicine float on the surface, so as to influence the extraction. Not only that, but the operation is * V complicated with the risk of dangerous steam. Extraction of Semen Cassiae by water is prone to cause problems of paste extracting tank or difficult draining.
In view of aforesaid problems, after repeated experimental researches, a new préparation method and a médicinal composition made by this new method hâve been developed.
DETAILED DESCRIPTION OF THE INVENTION
The objective of présent invention is to provide a pharmaceutical composition for treating headache.
Another objective of présent invention is to provide a preparing method of said composition.
Another objective of présent invention is to provide a use of said composition in préparation of drugs for treating headache, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminesso
The composition of présent invention comprises: 4-9 weight parts of Radix Angelicae Sinensis, 4-9 weight parts of Rhizoma Chuanxiong, 2-8 weight parts of Radix Paeoniae aiba, 2-8 weight parts of Radix Rehmanniae Preparata, 10-15 weight parts of Ramuius Uncariae cum Uncis, 10-15 weight parts of Cauiis Spathoiobi, 10-15 weight parts of Spica Pruneiiae, 10-15 weight parts of Semen Cassiae, 10-15 weight parts of Concha Margaritifera Usta, 4-9 weight parts of Rhizoma Corydaiis and 0.5-2 weight parts of Herba Asari. Said composition is prepared by a method as follows:
a) . Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with éthanol, and filtered to remove impurities; and the éthanol is recovered and concentrated to give #1 Extract for later use;
b) . Préparation of #2 Extract: Radix Paeoniae aiba is extracted by using heating refluxing with éthanol, and filtered; and the éthanol is recovered and concentrated to give #2 Extract for later use;
c) . Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum
Uncis, Cau/is Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are mixed, decocted with water, filtered, concentrated, into which éthanol is added to leave it to stand still, and filtered; and the éthanol is recovered and concentrated to give #3 Extract for later use;
d) . Préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried and granulated to obtain the final product.
Preferably, said composition of présent invention is prepared by a method as follows:
a). Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with 3~6 fold of 50-80% éthanol for 2-3 fîmes, the first time for 0.5-2.5 hours; the second and/or third time for 0.5-2 hours, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.250-1.350 (70-80°C) to give #1 Extract for later use;
b) . Préparation of #2 Extract: Radix Paeoniae aiba is added with 3-6 fold of
50-80% éthanol, soaked, extracted by using heating refluxing for 2-3 times, the first time for 0.5-2.5 hours, the second and/or third time for 0.5-2 hours, and filtered;
and the éthanol is recovered and concentrated until the relative density is 1.10-1.35 (55—65°C) to give #2 Extract for later use;
c) . Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 10 Uncis, Cau/is Spatholobi, Spica Prunellae, Concha Margaritifera Usta and Harba Asari are combined, decocted with 4-10 fold of water for 2-3 times, the first time for 0.5-3 hours, the second and/or third time for 1-3 hours, filtered, concentrated until the relative density is 1.06-1.10 (75~85°C), into which éthanol is added to make a final éthanol content of 60-85%, left to stand still for 12-24 hours, and filtered;
and the éthanol is recovered and concentrated until the relative density is
1.270-1.350 (75-85’C) to give #3 Extract for later use;
d) . Préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product.
More preferably, said composition of présent invention is prepared by a method as 20 follows:
a) . Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiaeaxe mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.300-1.310 (74-76’0) to give #1 Extract for later use;
b) . Préparation of #2 Extract: Radix Paeoniae aiba is added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.23-1.33 (65°C) to give #2 Extract for later use;
c) . Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spatholobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari are mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density is
1.06-1.10 (80°C), into which éthanol is added to make a final éthanol content of 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.320-1.325 (79-81 ’C) to give #3 Extract for later use;
d). Préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product.
Wherein, said excipients in step d) include one or more kinds of filling agent and flavoring agent.
Said filling agent is selected from one or more kinds of cellulose, starch, soluble starch, sugar powder, dextrin, mannitol, sucrose, lactose and microcrystalline cellulose, etc.
Said flavoring agent is selected from one or more kinds of steviosin, aspartame, glycerol, saccharin sodium, sorbitol, mannitol, xylitol, high fructose and sodium cyclamate.
Preferably, said filling agent is selected from dextrin, starch, soluble starch, sucrose, lactose and microcrystalline cellulose, and said flavoring agent is selected from steviosin and aspartame.
Most preferably, said filling agent is selected from dextrin and flavoring agent is selected from steviosin.
In one embodiment, the ratio of aforesaid three Extracts prepared by Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba, Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydaiis and Herba Asari to the excipients is 40:60 to 65:35 by weight percentage.
In another embodiment, the ratio of aforesaid three Extracts prepared by Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba, Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydaiis and Herba Asari to the excipients is 55:45 to 65:35 by weight percentage.
Wherein, aforesaid ratio is a ratio of the dried extractum converted from aforesaid three Extracts to the excipients.
According to présent invention, said pharmaceutical composition can be prepared into any one of pharmaceutically acceptable oral formulations, including, but not limited to, granules, tablets and capsules, etc, preferably the granules.
According to présent invention, said formulation may be prepared by any one of pharmaceutically acceptable methods, e.g. spray drying granulation method, f luidized-bed spray granulation method, wetting granulation method, dry granulation method and rolling granulation method.
Preferably, said formulation may be prepared by the fluidized-bed spray granulation method.
According to présent invention, said fluidized—bed spray granulation method comprises following steps: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well-stirring to give slurry; adding well-prepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters;
drying; granulating with a sieve; mixing totally and packaging to hâve the final product.
Wherein, the addition amount of said flavoring agent accounts for 0~1% by weight of the total filling agent. The ratio between the part of filling agent firstly 5 added and the rest of the filling agent is 1:4 to 1.5:1 by weight percentage.
According to présent invention, said pharmaceutical composition may be prepared into appropriate package spécification, which dépends on its various dosage forms, e.g. for the granules, the spécification can be selected from 3g/bag or 4g/bag.
îo According to présent invention, extracting method of said pharmaceutical composition is obtained by following screening experiments.
1. The reason why to extract 11 TCMs respectively
The main ingrédients of Radix Ange/icae Sinensis include: ferulic acid, capable of inhibiting blood coagulation and thrombus formation; water-soluble vitamin B12, 15 folie acid, folinic acid and nicotinic acid, capable of promoting génération of érythrocyte and hemoglobin significantly; and angelica polysaccharide, capable of facilitating growth of WBC reticular cell in mice and resisting anémia.
The main ingrédients of Rhizoma Chuanxiong include spécial smell volatile oil-like alkaloids, ferulic acid and volatile oil, etc. The alcohol extract of the Rhizoma 20 Chuanxiong has effects of dilating coronary artery, increasing coronary blood flow, protecting myocardium against ischemia, reducing blood pressure significantly, anticoagulation and anti-thrombus, etc. Besides, the tetramethylpyrazine therein is capable of sédation, dilating blood vascular, protecting myocardium against ischemia, as well as reducing blood pressure, anticoagulation and anti-thrombus, 25 etc. The main bioactive ingrédients are éthanol soluble in both Rhizoma Chuanxiong and Radix Ange/icae Sinensis, so éthanol extraction is used.
Radix Paeoniae a/ba mainly contains a number of glycosides such as paeoniflorin, as well as volatile oil, tannins and sugar. Its total glycosides are proven to hâve effects of anti-inflammation, immune régulation, protecting liver, sédation and 30 analgesia, etc. Among them, the paeoniflorin is at the highest concentration, which is easily extracted with éthanol or hot water due to its ester structure. As a resuit, the extract by éthanol solution is more stable.
The main ingrédients of Rhizoma Corydaiis are numerous alkaloids, among which the tetrahydropalmatine, corydaline, corydaiis L and dehydrocorydaline are proven 35 to hâve the stronger biological functions, capable of significantly sedating, hypnotizing, reducing coronary résistance and increasing blood flow, etc. Ail of Rhizoma Corydaiis éthanol extract, vinegar extract and water extract are found to hâve effect of relieving pain, and the éthanol one has the best effect among others. At the same time, they hâve certain of central sédation effect. Its 40 alkaloid is mainly composed of quarternary amine alkali and tertiary amine alkali;
the former is water soluble and extracted with water. Both, however, can be
extracted with éthanol solution and the yield rate is high.
Semen Cassiae contains a sériés of ingrédients of physcion, chrysophanol, emodin, rhein and Semen Cassiae lactone. Thus, extraction-by-ethanol is reasonable.
Ramu/us Uncariae cum Uncis mainly contains various types of indole alkaloids, dominated by rhynchophylline and isorhynchophylline, as well as a little flavonoid.
Both its water décoction and extract hâve marked effects of sédation, relieving pain and reducing blood pressure. Therefore, extraction-by-water is reasonable.
For the rest in this pharmaceutical composition, Radix Rehmanniae Preparata, 10 Cauiis Spathoiobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari work as adjuvant drugs and courier drugs in this formula. The chemical ingrédients contained therein include alcohols, amino acids, sterols, anthraquinones, many kinds of sugars and a variety of essential trace éléments such as Fe. The water décoction thereof is found to hâve blood-enriching effect 15 of increasing RBC count, having hemoglobin increased, reducing blood sugar, reducing blood pressure and lowering blood lipid, etc. As a resuit, according to the requirements of formula and quality of bioactive ingrédients, the waterextracting-alcohol-precipitating method is used to extract the bioactive ingrédients.
On the basis of aforesaid analysis, the extraction-by-ethanol method is applied to the medicines of Radix Ange/icae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba, Rhizoma Corydaiis and Semen Cassiae', the water-extracting-alcoholprecipitating method to Radix Rehmanniae Preparata, Cauiis Spathoiobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari.
2. Investigation of extracting Radix Paeoniae aiba alone or in combination
Radix Paeoniae aiba is the main drug in the formula, whose main bioactive ingrédient, paeoniflorin, acts as a détermination indicator. The yield rate, paeoniflorin content and dissolvability were used as the indicators for investigation of extracting Radix Paeoniae aiba alone or in combination. Production processes 30 were designed respectively, wherein the 1st process included the steps of taking
Radix Paeoniae aiba at prescription dose, into which 5 fold of 70% éthanol was added to extract by refluxing twice, 2 hours for each time; and the 2nd process included the steps of taking Radix Paeoniae aiba, Radix Ange/icae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae at prescription dose, 35 into which 5 fold of 70% éthanol was added to extract by refluxing twice, 2 hours for each time. Résultant extracts were combined respectively, appropriate quantity of the extracts (approximately equal to 0.03g crude medicine of Radix Paeoniae aiba) were sucked, éthanol was added to a constant volume of 20ml, and filtered to get the liquid as the sample solution. The rest of the extracts was 40 dried to investigate their yield rate, paeoniflorin content and dissolvability.
Method for détermination of paeoniflorin
Apparatus and reagent
Agilent 1100 HPLC was equipped with quaternary pump, DAD, automatic sampler, online degasser and column thermostat.
Standard paeoniflorin (obtained from China Pharmaceutical Biological Products Analysis Institute), methanol (chromatographically pure), purified water, isopropanol, citric acid (analytically pure)
Chromatographie conditions: Agilent Zorbax SB-Cw column (250 mmx4.6mm, 5 μηη)
Mobile phase: isopropanol-methanol-5% citric acid solution (2:18:80)
Flow rate: 1.0ml/min; column température: 30°C; détection wavelength: 240nm
Préparation of testing solution: as mentioned before.
Préparation of standard solution: appropriate quantity of standard paeoniflorin was taken and weighed accurately to préparé the standard solution (with 1ml solution containing 0.015mg soluté) by adding 80% methanol.
Measuring method: 10ui testing and standard solutions were respectively sucked with accuracy, injected into the HPLC and measured.
The results were shown below.
Table 1 investigation of extracting Radix Paeoniae aiba alone or in combination
_. Paeoniflorin content
Process ,. , (mg/g)
1st process15.58
2nd process15.10
Yield rate (%) Dissolvability
2Q 63 Totally dissolved, good dissolvability
Black residues,
21.88 somewhat less dissolvability
As shown in the results, in terms of the paeoniflorin content, the extract prepared by extracting Radix Paeoniae aiba alone was slightly higher than that in combination (3.18%). In terms of the yield rate, the former was less than the latter. In terms of the dissolvability, the former was much better than the latter. Compared with the latter one, the former process had advantages of shorter concentration heating time, less paeoniflorin loss, increased transfer rate, and elevated content in product. Thus, considering various factors comprehensively, the process by extracting Radix Paeoniae aiba alone was reasonable.
3. Investigation of extracting Ramuius Uncariae cum Uncis in different ways Rhynchophylline content and yield rate were used as indicators for investigation of extracting Ramuius Uncariae cum Uncis in different ways (where Ramuius Uncariae cum Uncis is decocted earlier or later). A mixture of Radix Rehmanniae Preparata, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta, Ramuius
Uncariae cum Uncis and Herba Asari was taken at prescription dose. Production processes were designed respectively. 1st process was that aforesaid mixture was added with 6 fold of water, extracted for 3 times to hâve the extract, the first time for 2 hours, the second and third times for 1 hour. 2nd process was that Radix Rehmanniae Preparata, Cau/is Spathoiobi, Spica Prunellae and Concha Margaritifera Usta were added with 6 fold of water, extracted for 2 hours, filtered, and the résultant residues were mixed with the Ramuius Uncariae cum Uncis, extracted twice with 6 fold of water, each for 1 hour to hâve the extract. Rhynchophylline content and yield rate of afore-obtained extracts were measured respectively.
Method for détermination of rhynchophylline
Apparatus and reagent
Agilent 1100 HPLC was equipped with quaternary pump, DAD, automatic sampler, online degasser and column thermostat.
Standard rhynchophylline, methanol (chromatographically pure), purified water, triethylamine, glacial acetic acid (analytically pure)
Chromatographie conditions: Agilent Zorbax SB-Ci8 column (250 mmX4.6mm, 5 μηη)
Mobile phase: methanol-1 Ommol triethylamine solution (48:52), adjusted to pH=5.0 with acetic acid
Flow rate: 1.0ml/min; column température: 30°C; détection wavelength: 254nm
Préparation of standard solution: appropriate quantity of standard rhynchophylline was taken and weighed accurately to préparé the standard solution (with 1ml solution containing 10ug soluté) by adding methanol.
Préparation of testing solution: appropriate quantity (approximately equal to 2g crude medicine Ramuius Uncariae cum Uncis) of combined water extract was sucked, alkalified by adding 5ml ammonia water, extracted with chloroform for 3 times and combined, evaporated to dryness with water bath. The residues were dissolved by adding methanol to volume of 20ml, filtered to give the testing solution.
Measuring method: 10μΙ testing and standard solutions were respectively sucked with accuracy, injected into the HPLC and measured.
The results were shown below.
Table 2 investigation of extracting Ramuius Uncariae cum Uncis in different ways
Process rhynchophylline content (mg) Yield rate (%)
1st process 10.80 13.39
2nd process 10.92 12.96
As shown in the results, in terms of the rhynchophylline content, the extract
prepared by 1st process was almost the same as that by 2nd process. In terms of the yield rate, the extract prepared by 1st process was slightly higher than that by 2nd process, but the différence was slight. The inconvénient operation brought by 2nd process should be considered, for example the medicine perhaps floated on 5 the surface, which may influence extraction and cause potential safety hazard.
Due to its simplified process, easy operation and enhanced safety, the 1st process was reasonable.
As shown in pharmacological research, it is confirmed that said pharmaceutical composition has effects of ameliorating cérébral pial microcirculation, increasing 10 cérébral blood flow, relaxing vasospasm and stopping pain. As shown in pharmacodynamies experiment, compared with the one prepared by methods known in prior arts, the pharmaceutical composition has an excellent effect of treating headache.
Embodiments
Example 1
The following médicinal materials were taken: 253.5g of Radix AngeUcae Sinensis, 253.5g of Rhizoma Chuanxiong, 202.7g of Radix Paeoniae aiba, 202.7g of Radix Rehmanniae Preparata, 506.8g of Ramuius Uncariae cum Uncis, 506.8g of Cauiis 20 Spathoiobi, 506.8g of Spica Pruneiiae, 506.8g of Semen Cassiae, 506.8g of
Concha Margaritifera Usta, 253.5g of Rhizoma Corydaiis and 50.5g of Herba As a ri.
Préparation of #1 Extract: Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 25 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.310 (74~76°C) to give 253g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 60% éthanol, 30 soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density is 1.23-1.33 (65°C) to give 42g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 35 Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol was 40 recovered and concentrated until the relative density was 1.320-1.325 (79-81 °C) to give 305g of #3 Extract for later use.
300g of dextrin was dissolved with purified water, into which 3.0g steviosin was added to dissolve by well stirring to give slurry. 600g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~45°C), and the slurry was online filtered 5 with 60-100 mesh sifter.
250.0g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a température of 30-60°C, and dried.
The température was further increased to 80~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 2
The following médicinal materials were taken: 338g of Radix Angeh'cae Sinensis, 338g of Rhizoma Chuanxiong, 270.3g of Radix Paeoniae alba, 270.3g of Radix Rehmanniae Preparata, 675.7g of Ramuius Uncariae cum Uncis, 675.7g of Cauiis Spathoiobi, 675.7g of Spica Prunallae, 675.7g of Semen Cassiae, 675.7g of Concha Margaritifera Usta, 338g of Rhizoma Corydaiis and 67.3g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.310 (74~76°C) to give 335g of #1 25 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.33 (65°C) to give 55g of #2 Extract 30 for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 35 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-72%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.320-1.325 (79-81 °C) to give 420g of #3 Extract for later use.
83g of sucrose was dissolved with purified water by well stirring to give the slurry. 40 810g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~45°C),
and the slurry was online filtered with 60-100 mesh sifter.
320g rest of the sucrose was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fIuidized state in the fluid bed. The 5 materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
îo Example 3
The following médicinal materials were taken: 150g of Radix AngeUcae Sinensis, 150g of Rhizoma Chuanxiong, 225g of Radix Paeoniae a/ba, 225g of Radix Rehmanniae Preparata, 551g of Ramuius Uncariae cum Uncis, 551g of Cauiis Spathoiobi, 551g of Spica Pruneiiae, 551g of Semen Cassiae, 551g of Concha 15 Margaritifera U s ta, 225 g of Rhizoma Corydaiis and 19g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 5 fold of 70% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and 20 concentrated until the relative density was 1.250-1.310 (70~74°C) to give 210g of #1
Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 80% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and 25 concentrated until the relative density was 1.15-1.25 (65°C) to give 50g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and 30 the second time for 1 hour, filtered, concentrated until the relative density was
1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 60-65%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.27-1.320 (75~80°C) to give 545g of #3 Extract for later use.
231g of dextrin was dissolved with purified water, into which 3.0g steviosin was added to dissolve by well stirring to give the slurry. 805g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
151g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30-60 °C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules.
The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 4
The following médicinal materials were taken: 250g of Radix Angeiicae Sinensis, 250g of Rhizoma Chuanxiong, 250g of Radix Paeoniae aiba, 250g of Radix 10 Rehmanniae Preparata, 740g of Ramuius Uncariae cum Uncis, 740g of Cauiis
Spathoiobi, 740g of Spica Pruneiiae, 740g of Semen Cassiae, 740g of Concha Margaritifera U s ta, 250g of Rhizoma Corydaiis and 50 g of Herba Asari.
Préparation of #1 Extract: Radix Ange/icae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 15 times with 4 fold of 80% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.350 (75~80°C) to give 300g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 6 fold of 60% éthanol, 20 soaked, extracted by using heating refluxing for 3 times, the first time for 3 hours and the second time for 1 hour and the third time for 0.5 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.20-1.35 (60°C) to give 60g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 25 Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 8 fold of water, the first time for 3 hours and the second time for 2 hours, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 80-85%, left to stand still for 12-24 hours, and filtered; and the éthanol was 30 recovered and concentrated until the relative density was 1.30-1.350 (80~85°C) to give 425g of #3 Extract for later use.
80g of soluble starch was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 785g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of 35 résultant slurry was adjusted to 1.12-1.23 (42-50°C), and the slurry was online filtered with 60-100 mesh sifter.
330g rest of the soluble starch was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the 40 fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules.
The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 5
The following médicinal materials were taken: 338g of Radix AngeUcae Sinensis, 338g of Rhizoma Chuanxiong, 75g of Radix Paeoniae aiba, 75g of Radix Rehmanniae Preparata, 510g of Ramuius Uncariae cum Uncis, 510g of Cauiis Spathoiobi, 510g of Spica Pruneiiae, 510g of Semen Cassiae, 510g of Concha Margaritifera Usta, 337g of Rhizoma Corydaiis and 37g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 50% éthanol, the first time for 2 hours and the second time for 2 hours, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.350 (73~78°C) to give 330g of #1
Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 5 fold of 70% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 1 hour and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.35 (65°C) to give 15g of #2 Extract 20 for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 10 fold of water, the first time for 2 hours and the second time for 2 hours, filtered, concentrated until the relative density was 25 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 63-70%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.290-1.330 (78~83°C) to give 253g of #3 Extract for later use.
320g of dextrin was dissolved with purified water, into which 3g steviosin was 30 added to dissolve by well stirring to give the slurry. 598g of well-prepared three
Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42-50’C), and the slurry was online filtered with 60-100 mesh sifter.
240g rest of the dextrin was put into the granulator. A sériés of parameters were 35 adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30-60’0, and dried. The température was further increased to 70-90’C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. 40 The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
I
Example 6
The following médicinal materials were taken: 300g of Radix Angelicae Sinensis, 300g of Rhizoma Chuanxiong, 400g of Radix Paeoniae aiba, 400g of Radix Rehmanniae Preparata, 650g of Ramuius Uncariae cum Uncis, 650g of Cauiis 5 Spathoiobi, 650g of Spica Pruneiiae, 650g of Semen Cassiae, 650g of Concha
Margaritifera U s ta, 300g of Rhizoma Corydaiis and 50g of Herba Asari.
Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 3 times with 3 fold of 60% éthanol, the first time for 2 hours, the second time for 1 hour 10 and the third time for 0.5 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.29-1.340 (73~78°C) to give 315g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawos added with 4 fold of 80% éthanol, soaked, extracted by using heating refluxing for 3 times, the first time for 2 hours, the 15 second time for 1 hour and the third time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.18-1.33 (65°C) to give 90g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari 20 were mixed, decocted for 2 times with 7 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80 °C), into which éthanol was added to make a final éthanol content of 70-75%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.310-1.330 (77~82°C) 25 to give 375g of #3 Extract for later use.
84g of dextrin was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 780g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered 30 with 60-100 mesh sifter.
336g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The 35 température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 7
The following médicinal materials were taken: 338g of Radix Angelicae Sinensis, 338g of Rhizoma Chuanxiong, 300g of Radix Paeoniae aiba, 300g of Radix Rehmanniae Preparata, 413g of Ramuius Uncariae cum Uncis, 413g of Cauiis Spathoiobi, 413g of Spica Pruneiiae, 413g of Semen Cassiae, 413g of Concha 5 Margaritifera U s ta, 337g of Rhizoma Corydaiis and 75g of Herba As a ri.
Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 6 fold of 70% éthanol, the first time for 2 hours and the second time for 0.5 hour, and filtered to remove the impurities; and the éthanol was recovered and 10 concentrated until the relative density was 1.260-1.310 (74~76°C) to give 300g of #1
Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 6 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 2 hours, and filtered; and the éthanol was recovered and 15 concentrated until the relative density was 1.21-1.34 (55°C) to give 70g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 6 fold of water, the first time for 2 hours and 20 the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-75%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.300-1.300 (79-81 °C) to give 424g of #3 Extract for later use.
40g of dextrin was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 794g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42-50’0), and the slurry was online filtered with 60-100 mesh sifter.
163g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fIuidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 8
The following médicinal materials were taken: 450g of Radix Angelicae Sinensis,
450g of Rhizoma Chuanxiong, 350g of Radix Paeoniae aiba, 350g of Radix
Rehmanniae Preparata, 570g of Ramuius Uncariae cum Uncis, 570g of Cauiis
Spathoiobi, 570g of Spica Prunellae, 570g of Semen Cassiae, 570g of Concha Margaritifera Usta, 450g of Rhizoma Corydalis and 100g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 6 fold of 80% éthanol, the first time for 1 hour and the second time for 1 hour, and fîltered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.29-1.340 (73~78°C) to give 390g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 3 fold of 60% éthanol, 10 soaked, extracted by using heating refluxing for 2 times, the first time for 2.5 hours and the second time for 2 hours, and fîltered; and the éthanol was recovered and concentrated until the relative density was 1.17-1.33 (65°C) to give 65g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 15 Uncis, Cauiis Spathoiobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 9 fold of water, the first time for 3 hours and the second time for 3 hours, fîltered, concentrated until the relative density was 1.06-1.08 (80°C), into which éthanol was added to make a final éthanol content of 65-75%, left to stand still for 12-22 hours, and fîltered; and the éthanol was 20 recovered and concentrated until the relative density was 1.310-1.330 (77~82°C) to give 385g of #3 Extract for later use.
110g of dextrin was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 840g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant 25 slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online fîltered with 60-100 mesh sifter.
256g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The 30 materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 9
The following médicinal materials were taken: 253.5g of Radix Ange/icae Sinensis, 253.5g of Rhizoma Chuanxiong, 202.7g of Radix Paeoniae aiba, 202.7g of Radix Rehmanniae Preparata, 506.8g of Ramuius Uncariae cum Uncis, 506.8g of Cauiis Spathoiobi, 506.8g of Spica Prunellae, 506.8g of Semen Cassiae, 506.8g of 40 Concha Margaritifera Usta, 253.5g of Rhizoma Corydaiis and 50.5g of Herba
Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.250-1.310 (70~74°C) to give 253g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.33 (65°C) to give 42g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-75%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.27-1.320 (75~80°C) to give 305g of #3 Extract for later use.
300g of soluble starch was dissolved with purifîed water, into which 3.0g steviosin was added to dissolve by well stirring to give the slurry. 600g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
250.0g rest of the soluble starch was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 80~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 10
The following médicinal materials were taken: 338g of Radix Angeiicae Sinensis, 338g of Rhizoma Chuanxiong, 270.3g of Radix Paeoniae atba, 270.3g of Radix Rehmanniae Preparata, 675.7g of Ramuius Uncariae cum Uncis, 675.7g of Cauiis Spatho/obi, 675.7g of Spica Pruneiiae, 675.7g of Semen Cassiae, 675.7g of Concha Margaritifera Usta, 338g of Rhizoma Corydaiis and 67.3g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1
hour, and filtered to remove the impurities: and the éthanol was recovered and concentrated until the relative density was 1.280-1.320 (75~80°C) to give 335g of #1 Extract for later use.
Préparation of #2 Extract: RadixPaeoniae aiba was added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.33 (65°C) to give 55g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 60-65%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.315-1.320 (76~79°C) to give 420g of #3 Extract for later use.
80g of microcrystalline cellulose was dissolved with purified water, into which 3.0g aspartame was added to dissolve by well stirring to give the slurry. 810g of wellprepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
320g rest of the microcrystalline cellulose was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 11
The following médicinal materials were taken: 150g of Radix Angelicae Sinensis, 150g of Rhizoma Chuanxiong, 225g of Radix Paeoniae aiba, 225g of Radix Rehmanniae Preparata, 551g of Ramulus Uncariae cum Uncis, 551g of Cauiis Spathoiobi, 551g of Spica Pruneiiae, 551g of Semen Cassiae, 551g of Concha Margaritifera Usta, 225g of Rhizoma Corydalis and 19g of Herba Asari.
Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 5 fold of 70% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.290-1.300 (75~77°C) to give 210g of #1 Extract for later use.
Préparation of #2 Extract: RadixPaeoniae aibawas added with 4 fold of 80% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 2 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.15-1.25 (65°C) to give 50g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.310-1.315 (79~82°C) to give 545g of #3 Extract for later use.
231g of lactose was dissolved with purified water, into which 3.0g aspartame was added to dissolve by well stirring to give the slurry. 805g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
151g rest of the lactose was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 12
The following médicinal materials were taken: 250g of Radix AngeUcae Sinensis, 250g of Rhizoma Chuanxiong, 250g of Radix Paeoniae aiba, 250g of Radix Rehmanniae Preparata, 740g of Ramuius Uncariae cum Uncis, 740g of Cauiis Spathoiobi, 740g of Spica Pruneiiae, 740g of Semen Cassiae, 740g of Concha Margaritifera Usta, 250g of Rhizoma Corydaiis and 50g of Herba Asari.
Préparation of #1 Extract: Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 80% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.280-1.300 (75~77°C) to give 300g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 6 fold of 60% éthanol, soaked, extracted by using heating refluxing for 3 times, the first time for 2 hours, the second time for 1 hour and the third time for 0.5 hour, and filtered; and the éthanol
was recovered and concentrated until the relative density was 1.20-1.35 (60°C) to give 60g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari 5 were mixed, decocted for 2 times with 8 fold of water, the first time for 3 hours and the second time for 2 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 80-85%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.280-1.330 (75-80°C) 10 to give 425g of #3 Extract for later use.
80g of dextrin was dissolved with purified water, into which 3g aspartame was added to dissolve by well stirring to give the slurry. 785g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42-50°C), and the slurry was online filtered 15 with 60-100 mesh sifter.
330g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The 20 température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules.
The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Bénéficiai effects of said pharmaceutical compositions on treating headache hâve 25 been demonstrated by following 2 pharmacodynamie researches.
Pharmacodynamie Research 1. Ameliorating effect of pharmaceutical composition (YXQN) on nitroglycerin-induced migraine in rats
1. Materials
1.1 Animais: SD rats, male, weighing 180-200g were provided by Beijing 30 Weitongiihua Experimental Animal Technology Co., Ltd. The animais were raised in separate cages under natural light with excellent ventilation and free access to water and food. Animal diet was pellet feed purchased from Jinan Dakang Feed Inc. (Certificate No.: 364). Feeding environment for test animais was in accordance with the Régulation of Test Animais Tianjin.
1.2 Drug: tested drug was prepared by the method of Example 1 (YXQN-1), and comparison drug by the method of Chinese patent ZL20051 0073290.3 (YXQN-2). Both were provided by Tasly Pharmaceutical Co., Ltd. Qiyeanshen tabiet (Approval. No.: Z45022054), as a positive control drug, was produced by Guangxi Beihai Pharmaceutical Co., Ltd (LOT: 20130123). Daily dosage: 20mg per day.
1.3 Reagent: NOS assay kit, Coomassie brilliant blue protein assay kit and NO assay kit were purchased from Nanjing Jiancheng Science & technology Co., Ltd
(LOT:20120726), Rat 5-HT kit was purchased from Shanghai Jianglai Bio-tech Co., Ltd (LOT:12-05), ELISA kit was purchased from Shanghai Meilian Bio-tech Co., Ltd and rat DA ELISA kit was purchased from Shanghai Kaibo Bio-tech Co., Ltd. Normal saline and 10% chloral hydrate.
1.4 Apparatus: Shimadzu UV2100 ultraviolet spectrophotometer, FLUKO F6/10 high-shearing dispersion emulsifier, Hettich ROTANTA 460R high-speed refrigerated centrifuge, Electronic balance and ultrasound Doppler blood stream detector.
2. Method
2.1 Grouping and administration
Animais were randomly divided into 9 groups according to body weight, 10 rats in each group: the model group; positive control group; blank control group; high, middle and low dosage groups of YXQN-1 (1.562g, 0.781g and 0.391 extract/kg respectively); high, middle and low dosage groups of YXQN-2 (1.562g, 0.781g 15 and 0.391 extract/kg respectively). Preventively, YXQN-1, YXQN-2 and positive control groups were administrated for 10 consecutive days. Positive drug was given at a dosage of 20mg per day. Equal volume of normal saline was intragastrically administrated to model group and blank control group.
2.2 Establishment of behavior observation model
Except the blank control group, remaining rats received subcutaneous injection of nitroglycerin (10ml/kg). Experimental migrainous rat models were duplicated.
After administrated intragastrically, those rats, having two reddish ears and increased frequency of scratching head with forepaws, were taken as successful modeling. (1) Reddish ear: to observe the time the reddish ear appeared and 25 disappeared after modeling; (2) Scratching head: to observe the frequency of scratching head every 30min after modeling, the time scratching head appeared with consecutive scratching head for 5 times or more as the symbol, and the time scratching head disappeared with scratching head of less than 5 times during an interval, dépréssion and fatigue as the symbol.
2.3 détermination of bio-marker
Ail animal models were made and administrated in light of aforesaid method. Blood and brain were collected 4 hours after modeling to préparé blood and brain homogenates, and frozen reserved for later use. Method of chemical colorimetry was performed in accordance with the label of the kit to assay NO content and 35 NOS activity in sérum; as well as 5-HT, 5-HIAA, NA DA contents in brain.
2.4 Statistical management
Ail data were analyzed with SPSS 20.0 software, results were expressed as X±s and t-test was used between groups.
3. Results
3.1 Reddish ears
No reddish ear was observed in blank control group. Reddish ears appeared in YXQN-1, YXQN-2 and model group 3 min after modeling. Compared with the
model group, there was no significant différence in the time reddish ears appeared. After treatment, compared with the model group, the time reddish ears disappeared in middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01), however, no significant différence was found in 5 the YXQN-2 groups. Compared with the equal dosage group of YXQN-2, the high and middle dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 3.
Table 3 effect of YXQN-1 and YXQN-2 on the time reddish ears appeared and disappeared in rats (min, ^±s)
Groups n Reddish ear appeared (min) Reddish ear disappeared (min)
Blank control group 10 0 0
Model group 10 3.28±0.21 187.26±10.44
Qiyeanshen Tablet 10 3.66±0.50 109.45±14.22 *
YXQN-1 (High) 10 3.55±0.72 99.26±15.28 #
YXQN-1 (Middle) 10 3.44±0.52 111,87±9.92 ** #
YXQN-1 (Low) 10 3.15±0.33 126.95±9.10 *
YXQN-2 (High) 10 3.29±0.60 125.49±13.19
YXQN-2 (middle) 10 3.83±0.86 1 35.99±1 0.11
YXQN-2 (Low) 10 3.55±0.19 138.95±12.22
Compared with the model group, * P<0.05, ** P<0.01; compared with
YXQN-2, # P<0.05.
3.2 Frequency of scratching head
In the blank control group, scratching head occasionally appeared once or twice during a few period of time. At about 3rd min after modeling, scratching head 15 appeared in YXQN-1, YXQN-2 and model groups, having no statistical significance, as compared with the model group. After treatment, there were more times of scratching head during period of 0th~30th min and 30,h~60th min. Compared with the model group, the high, middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01) in frequency of scratching 20 head. The significant différence had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 4.
Table 4 effect of YXQN-1 and YXQN-2 on the frequency of scratching head in rats (Y±s) during each period of time
Group N Frequency Frequency
(0~30min) (30~60min)
Blank control group 10 0 0
Model group 10 1 7.9±1.1 86.4±17.1
Qiyeanshen Tablet 10 6.1 ±2.0 ** 30.4±2.7 *
YXQN-1 (High) 10 1 0.4±2.9 ** 26.9 + 5.1 ★ ★
YXQN-1 (Middle) 10 12.1 ±1.5 * # 37.3+3.7 * #
YXQN-1 (Low) 10 1 3.3 + 1.6 * # 49.6+3.6 * #
YXQN-2 (High) 10 12.5 + 2.4 45.9+4.1
YXQN-2 (middle) 10 15.3+2.5 50.2 + 5.6
YXQN-2 (Low) 10 16.3 + 2.8 55.5 + 2.9
Compared with the model group, * P<0.05, ** P<0.01; compared with YXQN-2, # P<0.05.
3.3 Level of NO and NOS in sérum
Compared with the model group, the sérum level of NO and NOS in rats in the high, middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01). The significant différence had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 5.
Tablet 5 effect of YXQN-1 and YXQN-2 on the sérum level of NO and NOS in rats (x±s)
Group N NO (pmol/L) NOS (U/ml)
Blank control group 10 30.64+11.18 20.84 + 1.89
Model group 10 130.21+11.39 47.84 + 1.91
Qiyeanshen Tablet 10 78.13 + 18.16 ** 28.78 + 3.75*
YXQN-1 (High) 10 83.76 + 17.94** 45.19 + 4.28 **
YXQN-1 (Middle) 10 96.10 + 11.73 * # 47.3 + 2.28 * #
YXQN-1 (Low) 10 107.72 + 15.9 * „ 49.31 ±1.53 · * #
YXQN-2 (High) 10 97.33 + 16.23 48.22 + 4.28
YXQN-2 (middle) 10 101.11+19.01 50.2 + 5.6
YXQN-2 (Low) 10 118.72 + 18.75 55.5 + 2.9
Compared with the model group, * P<0.05, ** P<O.O1; compared
YXQN-2, # P<0.05.
3.4 Contents of 5-HT, 5-HIAA and DA
Compared with the model group, the contents of 5-HT, 5-HIAA and DA in rats in the high, middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01). The significant différence had not yet been found in each dosage group of the YXQN-2. In terms of 5-HT and 5-HIAA, compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant différence (P<0.05). In terms of DA, compared with the equal dosage group of YXQN-2, the middle and high dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 6.
Table 6 effect of YXQN-1 and YXQN-2 on the contents of 5-HT, 5-HIAA and DA in
rats (-x±s)
Group n 5-HT (ng/g) 5-HIAA (mg/d) DA (ng/L)
Blank control group 10 201,7±7.8 125.23±11.22 49.33±10.51
Model group 10 126.6±7.8 247.48±1.10 65.16±12.90
Qiyeanshen Tablet 10 185.3±6.1* 129.65±3.10* 54.04±11.27
YXQN-1 (High) 10 185.2±2.8* 130.19±24.28 ** 56.01 ±11.51 *#
YXQN-1 (Middle) 10 171,9±3.3 * # 139.3±22.28 * # 59.11 ±1 0.85*#
YXQN-1 (Low) 10 158.3±4.6 * # 149.31 ±1.53 * # 61,08±10.51 *
YXQN-2 (High) 10 170.3±6.3 158.22±34.20 59.67±10.32
YXQN-2 (middle) 10 145.1 ±9.1 168.20±25.60 61,28±14.32
YXQN-2 (Low) 10 120.72±8.5 155.5±23.90 61,54±15.20
4. Conclusion
Said pharmaceutical composition of présent invention may ameliorate nitroglycerin-induced behavioral indices and biochemical indices in models of migraine rats. As shown in the research, said pharmaceutical composition of présent invention is proven to hâve an effect on ameliorating nitroglycerin-induced behavioral indices in models of migraine rats, which is better than the comparison drug.
Pharmacodynamie Research 2. Effect of pharmaceutical composition (YXQN) on change of cérébral blood flow in model of migraine rabbits
1. Materials
1.1 Commercially available 36 rabbits, weighing 2.2 ± 0.5kg, were randomly divided into 6 groups, 6 rabbits in each group. The animais were raised in laboratory of basic medicine college of Tianjin Medical University, under natural light with excellent ventilation and free access to water and food.
1.2 Drugs: tested drug was prepared by the method of Example 1 (YXQN-1), and comparison drug was prepared by the method of Chinese patent ZL200510073290.3 (YXQN-2). Both were provided by Tasly Pharmaceutical Co., Ltd.
1.3 Apparatus: ultrasound Doppler blood stream detector
2. Method
2.1 Grouping and administration
Animais were randomly divided into 6 groups according to body weight, 6 rabbits in each group: the model group; blank control group; high, and low dosage groups of YXQN-1 (0.782g and 0.391g extract/kg respectively); high and low dosage groups of YXQN-2 (0.782g and 0.391g extract/kg respectively). The model and blank control groups were administrated by gastric perfusion with equal volume of normal saline. Animal modeling method was the same as aforesaid Pharmacodynamie Research 1. Except treatment by drugs, the model group was administrated by ear vein injection of 5-HT (2mg/kg) for consecutive 3 days, and at 3rd day Diazepam injection (7.5mg/rabbit) was added. Cérébral blood flow was
assayed 30min after the last administration. The rabbits were fixed in rabbit hutch. 2MHz detector was used on the temporal to detect, with a sampling volume of 7mm and a depth of 26±2mm.
2. Statistical management
Ail results were expressed as £±s and t—test was used between groups.
Pl=2x (Vs-Vd) /(Vs+Vd)
PI: puise index
Vs: blood flow velocity of contraction peak
Vd: blood flow velocity of diastole end
Vm: mean blood flow velocity
3. Results
3.1 Vs, Vd, Vm and PI
Blood flow velocity in the blank control group remained unchanged. After modeling, the blood flow velocities in YXQN-1, YXQN-2 and model groups were 15 decreased, having no statistical significance, as compared with the model group.
After treatment, compared with the model group, the high and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01). The significant différence had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the high dosage group of 20 YXQN-1 had significant différence (P<0.05). The results were shown in Table 7.
Tablet 7 effect of YXQN-1 and YXQN-2 on the change of cérébral blood flow in rabbits (^±s)
Group n Vs (cm/s) Vd (cm/s) Vm (cm/s) PI
Blank control group 6 43.53±4.8 40.33±3.22 41,56±3.51 0.082±0.001
Model group 6 24.71 ±4.54 19.48±3.10 21,16±2.90 0.23±0.03
YXQN-1 (high) 6 39.23±5.84* 34.34±4.98 ** 35.01 ±4.23 0.22±0.03
YXQN-1 (low) 6 38.33±4.63* # 33.76±4.96 * # 34.08±3.51 0.21 ±0.03
YXQN-2(high) 6 30.22±4.31 28.13±4.20 30.55±5.32 0.23±0.03
YXQN-2(low) 6 29.18±5.5 27.99±4.90 27.34±4.20 0.21+0.03
4. Conclusion
Said pharmaceutical composition of présent invention may ameliorate change of 25 cérébral blood flow in model of migraine rabbits. As shown in this research, said pharmaceutical composition could improve the nitroglycerin-induced change of cérébral blood flow in migraine rabbits, which was better than the comparison drug.

Claims (10)

  1. What is claimed is:
    1. A pharmaceutical composition for treatment parts of Radix Angeiicae Sinensis, 4-9 weight weight parts of Radix Paeoniae aiba, 2-8 weight parts of Radix Rehmanniae Preparata, 10-15 weight parts of Ramuius Uncariae cum Uncis, 10-15 weight parts of Cauiis Spathoiobi, 10-15 weight parts of Spica Pruneiiae, 10-15 weight parts of Semen Cassiae, 10-15 weight parts of Concha Margaritifera Usta, 4-9 weight parts of Rhizoma Corydaiis and 0.5-2 weight parts of Harba Asari, characterized in that said composition is prepared by a method as follows:
    a), préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with éthanol, and filtered to remove impurities; and the éthanol is recovered and concentrated to give #1 Extract for later use;
    b), préparation of #2 Extract: Radix Paeoniae aiba is extracted by using heating refluxing with éthanol, and filtered: and the éthanol is recovered and concentrated to give #2 Extract for later use;
    c) . préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are mixed, decocted with water, filtered, concentrated, into which éthanol is added to leave it to stand still, and filtered; and the éthanol is recovered and concentrated to give #3 Extract for later use;
    d) . préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, and granulated to obtain the final product.
  2. 2. The composition according to claim 1, characterized in that said composition is prepared by a method as follows:
    a) , préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with 3~6 fold of 50-80% éthanol for 2-3 times, the first time for 0.5-2.5 hours, the second and/or third time for 0.5-2 hours, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.250-1.350 at 70-80°C to give #1 Extract for later use;
    b) , préparation of #2 Extract: Radix Paeoniae aiba is added with 3-6 fold of 50-80% éthanol, soaked, extracted by using heating refluxing for 2-3 times, the first time for 0.5-2.5 hours, the second and/or third time for 0.5-2 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.10-1.35 at 55-65°C to give #2 Extract for later use;
    c) . préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are combined, decocted with 4-10 fold of water for 2-3 times, the first time for 0.5-3 hours, the second and/or third time for 1-3 hours, filtered, concentrated until the relative density is 1.06-1.10 at 75~85°C, into which éthanol is added to make a final éthanol content of 60-85%, left to stand still for 12-24 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.270-1.350 at 75~85°C to give #3 Extract for later use;
    d). préparation of formulations: aforesaid three Extracts are added with
    5 appropriate amount of excipients, dried, granulated to obtain the final product.
  3. 3. The composition according to claim 2, characterized in that said composition is prepared by a method as follows:
    a), préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, 10 Rhizoma Corydaiis and Semen Cassiae are mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.300-1.310 at 74~76°C to give #1 Extract for later use;
    15 b), préparation of #2 Extract: Radix Paeoniae aiba is added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.23-1.33 at 65°C to give #2 Extract for later use;
    20 c). préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum
    Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density is
    1.06-1.10 at 80°C, into which éthanol is added to make a final éthanol content of 25 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.320-1.325 at 79-81 °C to give #3 Extract for later use;
    d). préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product.
  4. 4. The composition according to any one of claims 1-3, characterized in that said excipients in step d) include one or more kinds of filling agent and flavoring agent; preferably, said filling agent is selected from dextrin, starch, soluble starch, sucrose, lactose and microcrystalline cellulose; said flavoring agent is selected
    35 from steviosin, aspartame; most preferably, said filling agent is dextrin and said flavoring agent is steviosin.
  5. 5. The composition according to claim 1, characterized in that the weight ratio of aforesaid three Extracts prepared by Radix AngeUcae Sinensis, Rhizoma Chuanxiong,
    40 Radix Paeoniae aiba, Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis,
    Cauiis Spathoiobi, Spica Pruneiiae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydaiis and Herba Asari to the excipients is 40:60 to 65:35, preferably 55:45 to 65:35.
  6. 6. The composition according to claim 5, characterized in that said ratio of aforesaid three Extracts to the excipients is a ratio of dried extractum converted from aforesaid three Extracts to the excipients.
    5
  7. 7. The composition according to claim 1, characterized in that, in step d), the formulation is prepared by fluidized-bed spray granulation method, comprising following steps: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well—stirring to give slurry; adding wellprepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of 10 the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters; drying; granulating with a sieve; mixing totally and packaging to obtain the final product.
  8. 8. The composition according to claim 7, characterized in that addition amount of
    15 said flavoring agent accounts for 0-1% by weight of the total filling agent, and the weight ratio between the part of filling agent firstly added and the rest of the filling agent added later is 1:4 to 1.5:1.
  9. 9. A method for preparing the pharmaceutical composition of any one of claims
    20 1 -8, characterized in that the method comprising following steps:
    a), préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae are mixed, extracted by using heating refluxing with éthanol, and filtered to remove impurities; and the éthanol is recovered and concentrated to give #1 Extract for later use;
    25 b), préparation of #2 Extract: Radix Paeoniae aiba is extracted by using heating refluxing with éthanol, and filtered; and the éthanol is recovered and concentrated to give #2 Extract for later use;
    c) . préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari
    30 are mixed, decocted with water, filtered, concentrated, into which éthanol is added to leave it to stand still, and filtered; and the éthanol is recovered and concentrated to give #3 Extract for later use;
    d) . préparation of formulations: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well—stirring to give slurry;
    35 adding well-prepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters; drying; granulating with a sieve; mixing totally and packaging to obtain the final product.
  10. 10. Use of the pharmaceutical composition of any one of claims 1-8 in préparation of medicine for treating headache, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.
OA1201500253 2012-12-21 2013-12-19 Pharmaceutical composition for treating headache, and preparation method thereof. OA17543A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210562103.8 2012-12-21

Publications (1)

Publication Number Publication Date
OA17543A true OA17543A (en) 2017-02-13

Family

ID=

Similar Documents

Publication Publication Date Title
AU2013362431B2 (en) Pharmaceutical composition for treating headache, and preparation method thereof
CN102416139B (en) Chinese medicine composition for treating breast diseases
CN100584373C (en) Preparation process of medicine for treating cerebral apoplexy and its sequela
KR101088539B1 (en) Chinese medicinal compositions for treating headache, formulations and processes for preparation therof
CN113018405B (en) Traditional Chinese medicine composition for treating post-stroke depression and preparation method thereof
AU2015345884B2 (en) Drug or health care product preventing or treating liver and kidney damage-related diseases and use thereof
CN104225006A (en) Traditional Chinese medicine composition capable of invigorating Qi and relaxing bowels
CN104027428B (en) Preparation method of traditional Chinese medicine compound and application of traditional Chinese medicine compound in prevention and treatment of senile dementia
CN109224038B (en) Traditional Chinese medicine composition containing channel-inducing medicine evodia rutaecarpa for treating blood stasis collateral blocking type hepatic fibrosis and preparation method and application thereof
CN100371012C (en) Medicinal composition, and its preparing method and use
CN101716269B (en) Traditional Chinese medicine composition for treating hyperpiesia
CN102895387B (en) Kidney-yang-warming medicine composition, and preparation thereof and preparation method thereof
CN102670711B (en) White flower salviae miltiorrhizae extract for curing angiitis, preparation method and application
OA17543A (en) Pharmaceutical composition for treating headache, and preparation method thereof.
CN102813873A (en) Traditional Chinese medicine composition for treating mental diseases, and preparation method, application and quality control thereof
CN1695728A (en) Oral taking preparation of Chinese traditional medicine for nourishing the kidney and the lung
CN1321632C (en) Compound saussurea involucrata capsule and its preparation process
CN106466396B (en) Gynaecologic menstruation regulating sustained-release dropping pill and preparation method thereof
CN105617251B (en) Traditional Chinese medicine composition for treating depression and preparation method thereof
CN105106153B (en) A kind of papaya tablet
CN102973624A (en) Compound ginkgo leaf preparation and preparation method thereof
CN115814041A (en) A Chinese medicinal composition for treating headache, and its preparation method
CN101239138A (en) &#39;Zishuiqinggan&#39;oral preparation and preparation thereof
CN105617165A (en) Application of Chinese herbal composition to preparation of medicine for treating vagina hemorrhage